Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur Radiol ; 27(7): 2850-2859, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27966042

RESUMEN

OBJECTIVES: To evaluate the fertility of women eligible for surgical multiple myomectomy, but who carefully elected a fertility-sparing uterine artery embolization (UAE). METHODS: Non-comparative open-label trial, on women ≤40 years, presenting with multiple symptomatic fibroids (at least 3, ≥3 cm), immediate pregnancy wish, and no associated infertility factor. Women had a bilateral limited UAE using tris-acryl gelatin microspheres ≥500 µm. Fertility, ovarian reserve, uterus and fibroid sizes, and quality of life questionnaires (UFS-QoL) were prospectively followed. RESULTS: Fifteen patients, aged 34.8 years (95%CI 32.2-37.5, median 36.0, q1-q3 29.4-39.5) were included from November 2008 to May 2012. During the year following UAE, 9 women actively attempting to conceive experienced 5 live-births (intention-to-treat fertility rate 33.3%, 95%CI 11.8%-61.6%). Markers of ovarian reserve remained stable. The symptoms score was reduced by 66% (95%CI 48%-85%) and the quality of life score was improved by 112% (95%CI 21%-204%). Uterine volume was reduced by 38% (95%CI 24%-52%). Women were followed for 43.1 months (95%CI 32.4-53.9), 10 live-births occurred in 8 patients, and 5 patients required secondary surgeries for fibroids. CONCLUSION: Women without associated infertility factors demonstrated an encouraging capacity to deliver after UAE. Further randomized controlled trials comparing UAE and myomectomy are warranted. KEY POINTS: • Women without infertility factors showed an encouraging delivery rate after UAE. • For women choosing UAE over abdominal myomectomy, childbearing may not be impaired. • Data are insufficient to definitively recommend UAE as comparable to myomectomy. • Further randomized trials comparing fertility after UAE or myomectomy are warranted.


Asunto(s)
Fertilidad , Infertilidad/etiología , Leiomioma Epitelioide/terapia , Medición de Riesgo/métodos , Embolización de la Arteria Uterina/efectos adversos , Neoplasias Uterinas/terapia , Adulto , Femenino , Estudios de Seguimiento , Francia/epidemiología , Humanos , Infertilidad/epidemiología , Infertilidad/fisiopatología , Leiomioma Epitelioide/diagnóstico , Embarazo , Estudios Prospectivos , Calidad de Vida , Encuestas y Cuestionarios , Resultado del Tratamiento , Neoplasias Uterinas/complicaciones , Neoplasias Uterinas/diagnóstico
2.
Clin Neurol Neurosurg ; 112(6): 516-9, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20399009

RESUMEN

Intracranial malignant tumors during pregnancy are rare. Primary meningeal sarcoma with leiomyoblastic differentiation during pregnancy has not been reported. We present the case of a 25-year-old woman in the third trimester of pregnancy with a large intracranial tumor destructing the parietal calvaria and invasion of soft tissues. Histological examination revealed primary meningeal sarcoma with leiomyoblastic differentiation. A gross macroscopical resection of the tumor with removal of the infiltrated parietal calvaria was performed after delivery of a healthy baby through caesarean section. A mass on the head rapidly enlarging during pregnancy should be considered for a malignancy of intracranial origin. Early radiological exams as well as tumor resection followed by staging and multimodality treatment should be urgently performed.


Asunto(s)
Leiomioma Epitelioide/complicaciones , Neoplasias Meníngeas/complicaciones , Complicaciones Neoplásicas del Embarazo/patología , Sarcoma/complicaciones , Adulto , Encéfalo/patología , Cesárea , Terapia Combinada , Resultado Fatal , Femenino , Humanos , Recién Nacido , Leiomioma Epitelioide/patología , Leiomioma Epitelioide/terapia , Imagen por Resonancia Magnética , Neoplasias Meníngeas/patología , Neoplasias Meníngeas/terapia , Embarazo , Complicaciones Neoplásicas del Embarazo/terapia , Resultado del Embarazo , Sarcoma/patología , Sarcoma/terapia
4.
Gastroenterol Clin Biol ; 20(5): 502-5, 1996.
Artículo en Francés | MEDLINE | ID: mdl-8761149

RESUMEN

In patients successfully treated for hereditary retinoblastoma, the risk of developing a second non-ocular tumor has been reported. We report the first case of primary hepatic leiomyosarcoma in a 39 year-old woman who has been treated 37 years before for hereditary retinoblastoma of the left eye. The patient presented with right upper quadrant abdominal pain and fever. Histological diagnosis was made by liver biopsy. As surgical resection was impossible, chemotherapy with epirubicin, then ifosfamide, etoposide and cisplatin was performed. The patient died 22 months after diagnosis. Genetic abnormalities observed in hereditary retinoblastoma, which probably resulted in a predisposition to the development of hepatic cancer in this patient, were not investigated.


Asunto(s)
Neoplasias del Ojo/genética , Leiomioma Epitelioide , Neoplasias Hepáticas , Neoplasias Primarias Secundarias , Retinoblastoma/genética , Adulto , Neoplasias del Ojo/cirugía , Femenino , Humanos , Leiomioma Epitelioide/terapia , Neoplasias Hepáticas/terapia , Neoplasias Primarias Secundarias/terapia , Retinoblastoma/cirugía , Factores de Tiempo
5.
Ann Ital Chir ; 66(3): 329-34, 1995.
Artículo en Italiano | MEDLINE | ID: mdl-8526301

RESUMEN

Leiomyoblastoma of the stomach is a rare nosological entity (0.3% of all gastric tumors). During the last 13 years, the authors observed 7 of such tumors. In this paper, our cases are presented: these are discussed (together with a revision of the literature), particularly focusing on anatomo-pathological, diagnostic and therapeutic problems.


Asunto(s)
Leiomioma Epitelioide , Neoplasias Gástricas , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Leiomioma Epitelioide/diagnóstico , Leiomioma Epitelioide/terapia , Masculino , Persona de Mediana Edad , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA